Wize Pharma

Wize Pharma Financing Cash Flow

Delisted·Jan 10, 2019

The Net Financing Cash Flow of Wize Pharma (WIZP) as of Nov 19, 2026 is 197,000.00 USD. In the previous year, Net Financing Cash Flow was -360,000.00 USD — a change of -154.72% (higher).

Financing Cash Flow

197,000.00USD

YoY

-154.72%

Last updated:

Net Financing Cash Flow of Wize Pharma is 2020 197,000.00 USD. Net Financing Cash Flow of Wize Pharma was 2019 -360,000.00 USD. It decreases by -154.72% higher compared to the previous year.

The Wize Pharma Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2014
4.06 M USD
Jan 1, 2015
4.06 M USD
Jan 1, 2016
473,000.00 USD
Jan 1, 2017
1.54 M USD
Jan 1, 2018
4.91 M USD
Jan 1, 2019
-360,000.00 USD
Jan 1, 2020
197,000.00 USD
The Wize Pharma Financing Cash Flow history
YEARFinancing Cash FlowYoY
197,000.00USD-154.72%
-360,000.00USD-107.33%
4.91 MUSD+219.25%
1.54 MUSD+225.16%
473,000.00USD-88.34%
4.06 MUSD0.00%
4.06 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

Net Financing Cash Flow of Wize Pharma is 197,000.00 USD in 2020.

Net Financing Cash Flow of Wize Pharma changed from -360,000.00 USD to 197,000.00 USD, representing a -154.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Wize Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Wize Pharma

All Key Metrics — Wize Pharma